BC Platforms is a world leader in providing powerful genomic data management solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and information technologies. Founded in 1997, the Company has a strong scientific heritage underpinned by 18 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors. Our high performing genomic data management platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information. BC Platforms’ vision is to revolutionize drug development and clinical decision-making to bring personalized medicines to patients.
Our management team consists of industry leaders with over 90 years of combined experience in life sciences, computational biology and industrial technology. We currently provide solutions to over 50 leading international institutions in 18 countries including top-tier academic and hospital research groups, major pharmaceutical and agricultural companies. BC Platforms has global operations with its research and development located in Helsinki, Finland, and sales and marketing based in Basel, London, Boston, and Vancouver.
Our management team consists of industry leaders with over 90 years of combined experience in life sciences, computational biology and industrial technology. We currently provide solutions to over 50 leading international institutions in 18 countries including top-tier academic and hospital research groups, major pharmaceutical and agricultural companies. BC Platforms has global operations with its research and development located in Helsinki, Finland, and sales and marketing based in Basel, London, Boston, and Vancouver.
